Jeremy Haigh

Chief Executive Officer at Proteome Sciences PLC


Jeremy Haigh is the CEO of Proteome Sciences, a leading company in applied proteomics and peptidomics. Prior to this he was the European Chief Operating Officer in Research & Development at Amgen. He was responsible for Amgen’s Research & Development sites across Europe, the Middle East and Africa (EMEA), and for Global Development staff located in the region.

Jeremy’s experience across the pharmaceutical sector in both clinical trials and organisational governance and development is vast.

His areas of expertise are clinical research – especially neurological diseases, leadership in the biosciences sector and organisational development.

Contact Jeremy

Phone : (1)-1234-4444
Email :

Jeremy's Projects

Related Team Members

Paul Stefanoski

Chair of FAR

Rob Hurd

Chief Executive of North West London Integrated Care Board

Sir Mark Walport

Chair Imperial College Health Partners